Cardiff Oncology (CRDF) Common Equity (2011 - 2026)
Cardiff Oncology's Common Equity came in at $26.53 million for Q2 2026, down 54.7% from $58.61 million a year earlier.
Powered by 
Analysis
Cardiff Oncology (CRDF) Common Equity (2011 - 2026) Analysis & Trends
At the end of FY2025, Cardiff Oncology's Common Equity was $45.39 million, down 45.3% from FY2024.
- Common Equity carries a five-year compound annual growth rate of -18.7% (FY2020 to FY2025).
- Going back by year, Common Equity was $82.95 million in FY2024 (+18.9%), $69.74 million in FY2023 (-34.4%), $106.34 million in FY2022 (-24.3%) and $140.42 million in FY2021 (+9.6%).
- The Q2 2026 figure represents the lowest quarterly Common Equity since Q2 2020.
- Year-over-year, Common Equity increased in three of the last seven quarters, with an average decline of 12.9%.
- The fastest year-over-year change in Common Equity over five years came in Q3 2021 (growth of 298.4%), and the weakest in Q2 2026 (a decline of 54.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,162.99 Bn | 1,131.58 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 633.71 Bn | 552.23 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 502.40 Bn | 475.51 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 376.48 Bn | 330.86 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 303.61 Bn | 267.60 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 267.02 Bn | 240.70 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 240.85 Bn | 196.25 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 193.39 Bn | 167.58 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 172.14 Bn | 118.78 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Cardiff Oncology | 66.35 Mn | 31.85 Mn | - | 26.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.53 Mn |
| Dec 31, 2025 | 45.39 Mn |
| Sep 30, 2025 | 48.79 Mn |
| Jun 30, 2025 | 58.61 Mn |
| Mar 31, 2025 | 70.88 Mn |
| Dec 31, 2024 | 82.95 Mn |
| Sep 30, 2024 | 49.39 Mn |
| Jun 30, 2024 | 52.39 Mn |
| Mar 31, 2024 | 60.89 Mn |
| Dec 31, 2023 | 69.74 Mn |
| Sep 30, 2023 | 77.83 Mn |
| Jun 30, 2023 | 86.58 Mn |
| Mar 31, 2023 | 96.50 Mn |
| Dec 31, 2022 | 106.34 Mn |
| Sep 30, 2022 | 113.21 Mn |
| Jun 30, 2022 | 120.47 Mn |
| Mar 31, 2022 | 130.10 Mn |
| Dec 31, 2021 | 140.42 Mn |
| Sep 30, 2021 | 133.54 Mn |
| Jun 30, 2021 | 138.92 Mn |
API Access
Cardiff Oncology Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=CRDF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "CRDF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=CRDF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();